Takimoto Chris H
SEC insider (Form 3/4/5 filer). CIK 0001743780. Director at ALX ONCOLOGY HOLDINGS INC (ALXO) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 20, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Takimoto Chris H has filed insider reports for
- ALX ONCOLOGY HOLDINGS INC (ALXO): Director
- IGM Biosciences, Inc. (IGMS): Officer, CHIEF MEDICAL OFFICER
Takimoto Chris H
CIK: 0001743780
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 20, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
40.4K shares- - Jan 21, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectCommon Stock (right to buy)
40.4K shares- - Sep 13, 2024IGMS
IGM Biosciences, Inc.
SaleDirect1.5K shares at avg. $11.54$17K
1-3 of 3 transactions